Most recent by Edward T.A. Fry, MD, FACC, FSCAI
Team-based telehealth approach improves medication use in high-risk patients with diabetes
ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.
Paid incentives, games boost daily steps for people at high risk for heart disease
ATLANTA — In a study of behavioral economics, researchers reported benefits of gamification and money incentives to boost daily step count for patients at high risk for CVD.
Intravenous iron supplementation improved CV outcomes for patients with HF, iron deficiency
CHICAGO — In the IRONMAN trial, long-term IV iron supplementation in patients with HF and iron deficiency was safe and reduced risk for recurrent HF hospitalizations and CV death compared with usual care.
No difference in CV outcomes with two common diuretics among veterans with hypertension
CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.
In patients with CAD, P2Y12 inhibitors best aspirin for secondary prevention
Among patients with CAD, P2Y12 monotherapy was superior to aspirin monotherapy for prevention of CV death, MI and stroke, according to an individual patient data meta-analysis presented at the European Society of Cardiology Congress.
In angiography, transradial access bests transfemoral access for 30-day mortality, bleeding
In a meta-analysis of seven trials of patients who had coronary angiography with or without PCI, those who had transradial access had lower 30-day rates of mortality and major bleeding compared with those who had transfemoral access.